|
HIVEP2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.22030005492257E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.50820003339692E-09 |
| Normal-vs-Stage2 |
1.76519998618119E-09 |
| Normal-vs-Stage3 |
2.35010000348979E-09 |
| Normal-vs-Stage4 |
1.25929999761354E-08 |
| Stage1-vs-Stage2 |
1.869420E-01 |
| Stage1-vs-Stage3 |
3.143200E-01 |
| Stage1-vs-Stage4 |
3.589600E-01 |
| Stage2-vs-Stage3 |
6.082400E-01 |
| Stage2-vs-Stage4 |
7.260000E-01 |
| Stage3-vs-Stage4 |
8.944000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.63110000453537E-09 |
| Normal-vs-AfricanAmerican |
3.559900E-02 |
| Normal-vs-Asian |
4.75330000027085E-07 |
| Caucasian-vs-AfricanAmerican |
1.335610E-01 |
| Caucasian-vs-Asian |
8.399000E-01 |
| AfricanAmerican-vs-Asian |
1.862650E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.67650038085787E-10 |
| Normal-vs-Female |
6.48429998584277E-09 |
| Male-vs-Female |
1.421640E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.64219999505045E-08 |
| Normal-vs-Age(41-60Yrs) |
1.25090005020922E-09 |
| Normal-vs-Age(61-80Yrs) |
3.49750006733984E-10 |
| Normal-vs-Age(81-100Yrs) |
3.212000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.169760E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.449900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.017600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.545200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.722800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.385000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.202200E-01 |
| Classical-VS-Follicular |
4.30399999999942E-05 |
| Classical-VS-Other |
1.973650E-01 |
| Classical-VS-Normal |
1.68829999980247E-07 |
| Tall-VS-Follicular |
1.408970E-01 |
| Tall-VS-Other |
3.719000E-01 |
| Tall-VS-Normal |
2.60119999984099E-07 |
| Follicular-VS-Other |
9.333200E-01 |
| Follicular-VS-Normal |
2.73879807721755E-11 |
| Other-VS-Normal |
3.67330000000665E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.96549998499052E-10 |
| Normal-vs-N1 |
2.22719999998233E-07 |
| N0-vs-N1 |
3.338200E-01 |
|
|
